Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...

Patients with worse lung function, a greater extent of fibrosis on HRCT, or a UIP pattern on HRCT are ... Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary ...

Introduction Antifibrotics slow progression and improve survival in idiopathic pulmonary fibrosis (IPF). There are limited data on real-world antifibrotic treatment patterns in patients with IPF in ...

pulmonary function tests, high-resolution CT (HRCT) findings and lung biopsy findings. HRCT findings, such as bilateral areas with ground-glass attenuation, reticular opacities and honeycomb patterns, ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

Idiopathic pulmonary fibrosis is a chronic, progressive, incurable lung disease, leading to irreversible lung tissue ...

Honeycomb serves more than 60% of the U.S. population, insuring assets with a total insured value of more than $35 Billion across states including Arizona, California, Connecticut, Georgia ...